Peggy Gnegy Univ Michigan Medical School
Jayne Reuben Texas A & M University
L’Aurelle Johnson - University of Minnesota School of Pharmacy
Using the fundamental concept of signal transduction, this session will highlight how pharmacology intersects diversity, equity, and inclusion (DEI). We will explore the process of DEI reception, transduction, and response.
Wilson Compton - NIDA, NIH
The misuse of and addiction to and an alarming resurgence in stimulant use is contributing to a rise in overdose fatalities that is also exacerbating health disparities among minority groups. This crisis has been fueled by the COVID-19 pandemic. This presentation will highlight how NIH researchers are using scientific advances to develop new treatments as well as prevention and treatment interventions in healthcare and justice settings that aim for equity in access to the support needed for recovery.
Asa Radix - Callen-Lorde Community Health Center, NY
This presentation will describe best practices for clinical management of trans and gender diverse adults. The lecture will describe the evolution of clinical practice guidelines from 1979 - present, discuss what is known about health outcomes for people receiving gender affirming hormone therapy and summarize research related to applicability of sex-based algorithms for transgender people.
Behavioral Pharmacology
Cancer Pharmacology
Cardiovascular Pharmacology
Drug Discovery and Development
Drug Metabolism and Disposition
Molecular Pharmacology
Neuropharmacology
Pharmacology Education
Toxicology
Translational and Clinical Pharmacology
Saturday
Sunday
Tuesday